EXANE DERIVATIVES - AMEDISYS INC ownership

AMEDISYS INC's ticker is AMED and the CUSIP is 023436108. A total of 287 filers reported holding AMEDISYS INC in Q2 2022. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
EXANE DERIVATIVES ownership history of AMEDISYS INC
ValueSharesWeighting
Q1 2022$861,000
+6.4%
50.0%0.00%
Q4 2021$809,000
-97.9%
5
-98.1%
0.00%
-100.0%
Q3 2021$39,361,000
-95.9%
264
-92.7%
0.01%
-95.9%
Q2 2021$957,667,000
+261.6%
3,625
+301.4%
0.22%
+178.2%
Q4 2020$264,865,000
+207.8%
903
+148.1%
0.08%
+212.0%
Q3 2020$86,056,0003640.02%
Other shareholders
AMEDISYS INC shareholders Q2 2022
NameSharesValueWeighting ↓
RIVERBRIDGE PARTNERS LLC 1,693,656$291,800,0003.30%
Kent Lake Capital LLC 30,000$5,169,0003.21%
Lipe & Dalton 22,802$3,929,0001.92%
RK Capital 54,900$9,459,0001.86%
Millrace Asset Group, Inc. 14,651$2,524,0001.83%
Integral Health Asset Management, LLC 40,000$6,892,0001.79%
Bridge City Capital, LLC 19,175$3,304,0001.54%
Sivik Global Healthcare LLC 20,000$3,446,0001.42%
Bell Asset Management Ltd 47,207$8,133,0001.40%
Advantage Alpha Capital Partners LP 53,680$9,249,0001.38%
View complete list of AMEDISYS INC shareholders